Table 1 Prevalence of COPD-related PH in patients with COPD during 2009 to 2018.
From: A prevalence study focusing on hospitalized COPD related pulmonary hypertension
Year | Overall | Male | Female | |||
|---|---|---|---|---|---|---|
COPD patient | COPD-related PHb | COPD patients | COPD-related PHb | COPD patients | COPD-related PHb | |
2009 | 22,454 | 44.8 | 16,886 | 45.9 | 5,568 | 41.7 |
2010 | 23,247 | 42.6 | 17,525 | 44.6 | 5,722 | 36.4 |
2011 | 23,911 | 39.1 | 18,236 | 40.3 | 5,675 | 35.2 |
2012 | 22,494 | 40.7 | 17,257 | 41.5 | 5,237 | 38.0 |
2013 | 20,472 | 41.7 | 15,703 | 42.4 | 4,769 | 39.4 |
2014 | 19,702 | 39.4 | 15,118 | 39.8 | 4,584 | 38.4 |
2015 | 19,495 | 40.9 | 15,147 | 41.3 | 4,348 | 39.6 |
2016 | 21,436 | 40.7 | 16,329 | 40.8 | 5,107 | 40.5 |
2017 | 21,515 | 35.7 | 16,317 | 34.7 | 5,198 | 38.9 |
2018 | 20,566 | 33.1 | 15,797 | 30.4 | 4,769 | 41.9 |
Totala | 215,292 | 39.9* | 164,315 | 40.2* | 50,977 | 38.9* |
